oxybutynin has been researched along with resiniferatoxin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Fowler, CJ | 1 |
Cannon, TW; Chancellor, MB | 1 |
Aslan, AR; Kogan, BA | 1 |
Baracat, EC; Haddad, JM; Matsuoka, PK; Pacetta, AM | 1 |
Cano, A; Cardoso, JC; Cirino, LMD; de Albuquerque JĂșnior, RLC; Novais, GB; Padilha, FF; Severino, P; Souto, EB; Vergne, DMC | 1 |
4 review(s) available for oxybutynin and resiniferatoxin
Article | Year |
---|---|
Intravesical treatment of overactive bladder.
Topics: Administration, Intravesical; Anesthetics, Local; Atropine; Capsaicin; Cholinergic Antagonists; Diterpenes; Humans; Mandelic Acids; Neurons, Afferent; Neurotoxins; Urinary Bladder Diseases; Urinary Incontinence | 2000 |
Pharmacotherapy of the overactive bladder and advances in drug delivery.
Topics: Administration, Intravesical; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxins; Capsaicin; Cholinergic Antagonists; Cresols; Cystitis, Interstitial; Diterpenes; Humans; Mandelic Acids; Neurotoxins; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases; Urination Disorders | 2002 |
Conservative management in neurogenic bladder dysfunction.
Topics: Anti-Dyskinesia Agents; Benzhydryl Compounds; Biofeedback, Psychology; Botulinum Toxins; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Diterpenes; Electric Stimulation Therapy; Humans; Infant; Infant, Newborn; Mandelic Acids; Meningomyelocele; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Catheterization | 2002 |
Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anesthetics, Local; BCG Vaccine; Cystitis, Interstitial; Diterpenes; Humans; Lidocaine; Mandelic Acids; Muscarinic Antagonists; Neurotoxins | 2012 |
1 other study(ies) available for oxybutynin and resiniferatoxin
Article | Year |
---|---|
Liposomal formulations of oxybutynin and resiniferatoxin for the treatment of urinary diseases: improvement of drug tolerance upon intravesical.
Topics: Animals; Diterpenes; Drug Tolerance; Female; Liposomes; Mandelic Acids; Rats; Rats, Wistar | 2022 |